Evidence map›Paper›PMID 27149221›Full record

ArticleBiochemistry2016

Mechanism of Human Nucleocytoplasmic Hexosaminidase D.

Matthew G Alteen, Verena Oehler, Ivana Nemčovičová, Iain B H Wilson, David J Vocadlo, Tracey M Gloster

Open access · hybridAbstract read
In one paragraph

Article in Biochemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Characterization ofInternational journal of molecular sciences · 2019
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Matthew G AlteenDepartment of Chemistry, Simon Fraser University , 8888 University Drive, Burnaby, BC V5A 1S6, Canada.
Verena OehlerBiomedical Sciences Research Complex, University of St Andrews , North Haugh, St Andrews, Fife KY16 9ST, U.K.
Ivana NemčovičováDepartment für Chemie, Universität für Bodenkultur , Muthgasse 18, A-1190 Wien, Austria.
Iain B H WilsonDepartment für Chemie, Universität für Bodenkultur , Muthgasse 18, A-1190 Wien, Austria.
David J VocadloDepartment of Chemistry, Simon Fraser University , 8888 University Drive, Burnaby, BC V5A 1S6, Canada.
Tracey M GlosterBiomedical Sciences Research Complex, University of St Andrews , North Haugh, St Andrews, Fife KY16 9ST, U.K.
BOKU University · ATSimon Fraser University · CA

Funding

CIHR MOP123341Wellcome Trust 095828
6 · The paper itself

Abstract

Mammalian β-hexosaminidases have been shown to play essential roles in cellular physiology and health. These enzymes are responsible for the cleavage of the monosaccharides N-acetylglucosamine (GlcNAc) and N-acetylgalactosamine (GalNAc) from cellular substrates. One of these β-hexosaminidases, hexosaminidase D (HexD), encoded by the HEXDC gene, has received little attention. No mechanistic studies have focused on the role of this unusual nucleocytoplasmically localized β-hexosaminidase, and its cellular function remains unknown. Using a series of kinetic and mechanistic investigations into HexD, we define the precise catalytic mechanism of this enzyme and establish the identities of key enzymic residues. The preparation of synthetic aryl N-acetylgalactosaminide substrates for HexD in combination with measurements of kinetic parameters for wild-type and mutant enzymes, linear free energy analyses of the enzyme-catalyzed hydrolysis of these substrates, evaluation of the reaction by nuclear magnetic resonance, and inhibition studies collectively reveal the detailed mechanism of action employed by HexD. HexD is a retaining glycosidase that operates using a substrate-assisted catalytic mechanism, has a preference for galactosaminide over glucosaminide substrates, and shows a pH optimum in its second-order rate constant at pH 6.5-7.0. The catalytically important residues are Asp148 and Glu149, with Glu149 serving as the general acid/base residue and Asp148 as the polarizing residue. HexD is inhibited by Gal-NAG-thiazoline (Ki = 420 nM). The fundamental insights gained from this study will aid in the development of potent and selective probes for HexD, which will serve as useful tools to improve our understanding of the physiological role played by this unusual enzyme.

Indexed as

CatalysisEnzyme InhibitorsHexosaminidasesHumansHydrogen-Ion ConcentrationHydrolysisKineticsThiazolidinesEnzyme InhibitorsHexosaminidasesThiazolidines

Identifiers

PMID27149221
PMCPMC4878814
OpenAlexW2346584176

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.